[68Ga]Ga-FAPI-04 PET/CT评估克罗恩病肠道病变
研究纳入16例克罗恩病患者,评估了74个肠段,在1周内完成CTE、[68Ga]Ga-FAPI-04 PET/CT和回结肠镜检查。FAPI PET/CT对镜下病变的检出灵敏度为93.3%(42/45),CTE为86.7%(39/45),ROC分析显示FAPI PET/CT检出镜下病变的表现优于CTE(P<0.05)。
要点
- FAPI PET/CT检出镜下病变灵敏度93.3%(42/45),CTE为86.7%(39/45),前者表现更优(P<0.05)。
- TBR与CTE评分(r=0.81)及SES-CD(r=0.86)显著相关,P均<0.0001。
- 整体FAPI PET/CT评分与FCP、CRP、CDEIS、CDAI均显著相关。
核心结论
- [68Ga]Ga-FAPI-04 PET/CT与克罗恩病的内镜、CTE、临床及生物标志物指标相关性良好,对全部肠段不同类别病变的检出灵敏度高,且无需患者禁食或肠道准备,作者认为其可能是评估克罗恩病活动性的有前景的方法。
研究设计与样本
- 所有克罗恩病患者在1周内接受CTE、[68Ga]Ga-FAPI-04 PET/CT检查和回结肠镜检查。
- 两名独立的胃肠病学家计算所有患者的克罗恩病活动指数(CDAI)。
- 两名放射科医师分别评估CTE图像并计算CTE评分;两名核医学医师独立阅[68Ga]Ga-FAPI-04 PET/CT图像。
- 当肠段FAPI摄取等于或高于肝脏时视为FAPI阳性,计算靶本比(TBR)和整体FAPI PET/CT评分,分别代表独立肠道活动和全部肠段活动。
- 在内镜检查前测定粪便钙卫蛋白(FCP)和C反应蛋白(CRP)水平,内镜检查时计算克罗恩病内镜严重程度指数(CDEIS)和克罗恩病简化内镜评分(SES-CD)。
主要发现
- 共评估16例患者的74个肠段。
- [68Ga]Ga-FAPI-04 PET/CT检出45个镜下病变肠段中的42个(镜下病变检出灵敏度93.3%),CTE检出39个(镜下病变检出灵敏度86.7%)。
- ROC分析显示,[68Ga]Ga-FAPI-04 PET/CT检出镜下病变的表现优于CTE(P<0.05)。
- TBR与CTE评分显著相关(r=0.81;95%CI 0.736-0.869;P<0.0001),与SES-CD值显著相关(r=0.86;95%CI 0.776-0.908;P<0.0001)。
- 整体FAPI PET/CT评分与FCP显著相关(r=0.52;95%CI 0.02-0.81;P=0.039),与CRP显著相关(r=0.60;95%CI 0.13-0.85;P=0.014),与CDEIS显著相关(r=0.55;95%CI 0.06-0.83;P=0.028),与CDAI显著相关(r=0.81;95%CI 0.50-0.93;P<0.0001)。
关键数值与推荐
- 肠段FAPI摄取等于或高于肝脏时判定为FAPI阳性。
- 镜下病变检出灵敏度:[68Ga]Ga-FAPI-04 PET/CT为93.3%(42/45),CTE为86.7%(39/45)。
- TBR与CTE评分相关系数r=0.81(95%CI 0.736-0.869;P<0.0001),与SES-CD相关系数r=0.86(95%CI 0.776-0.908;P<0.0001)。
- 整体FAPI PET/CT评分与FCP相关系数r=0.52(95%CI 0.02-0.81;P=0.039),与CRP相关系数r=0.60(95%CI 0.13-0.85;P=0.014),与CDEIS相关系数r=0.55(95%CI 0.06-0.83;P=0.028),与CDAI相关系数r=0.81(95%CI 0.50-0.93;P<0.0001)。
临床怎么用
- 作者认为[68Ga]Ga-FAPI-04 PET/CT可能是评估克罗恩病活动性的有前景的方法。
- 该技术无需患者禁食或肠道准备,不同于其他检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fibrosis and inflammation are major pathological changes of Crohn's disease (CD). Early detection and accurate severity evaluation of CD are critical for patient's prognosis. Endoscopy is widely used to evaluate CD progression. Herein, we evaluated the efficacy of [68Ga]Ga-FAPI-04 PET/CT to identify lesions and assess the progression of CD. METHODS: All CD patients received computed tomography enterography (CTE), [68Ga]Ga-FAPI-04 PET/CT examination, and ileocolonoscopy within 1 week. Two independent gastroenterologists computed the Crohn's disease activity index (CDAI) of all patients. Two radiology physicians assessed the CTE images separately, and the CTE scores were calculated. Lastly, two nuclear medicine physicians independently examined the [68Ga]Ga-FAPI-04 PET/CT images. Once the FAPI uptake of the intestinal segment was equal or higher relative to the liver (considered FAPI-positive), the target-to-background ratio (TBR) and global FAPI PET/CT score were computed, representing the independent intestinal activity and activity of all intestinal segments, respectively. Levels of fecal calprotectin (FCP) and C-reactive protein (CRP) were determined before the endoscopy. The Crohn's disease endoscopy index of severity (CDEIS) and the simple endoscopic score for Crohn's disease (SES-CD) were calculated during the endoscopy. Finally, all data were obtained and analyzed. RESULTS: There were 74 intestinal segments in 16 patients were assessed. [68Ga]Ga-FAPI-04 PET/CT identified 42 of 45 endoscopically lesioned segments (endoscopic lesions detection sensitivity: 93.3%), while CTE identified 39 of them (endoscopic lesions detection sensitivity: 86.7%). According to the receiver operating characteristic (ROC) analysis, [68Ga]Ga-FAPI-04 PET/CT showed better performance in the detection of endoscopic lesions compared with CTE (P < 0.05). The TBR was significantly associated with the CTE score (r = 0.81; (95% CI): 0.736-0.869; P < 0.0001) and SES-CD values (r = 0.86; (95% CI): 0.776-0.908; P < 0.0001). In addition, the global FAPI PET/CT score was significantly correlated with FCP (r = 0.52; 95% CI, 0.02-0.81; P = 0.039), CRP (r = 0.60; 95% CI, 0.13-0.85; P = 0.014), CDEIS (r = 0.55; 95% CI, 0.06-0.83; P = 0.028), and CDAI (r = 0.81; 95% CI, 0.50-0.93; P < 0.0001). CONCLUSION: In summary, [68Ga]Ga-FAPI-04 PET/CT correlated well with endoscopic, CTE, clinical, and biomarkers of CD. It was also highly sensitive in the detection of different classes of lesions in all intestinal segments, and unlike other examinations, this technique required no patient fasting or bowel preparation. Therefore, [68Ga]Ga-FAPI-04 PET/CT may be a promising method for assessing the activity of CD.
引用
- Chen L, Zhong X, Li L, et al. [68Ga]Ga-FAPI-04 PET/CT on assessing Crohn's disease intestinal lesions. Eur J Nucl Med Mol Imaging. 2023. PMID: 36631715. doi:10.1007/s00259-023-06107-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。